Bitdeer Technologies
BTDR
Mawson Infrastructure
MIGI
Digihost Technology
DGHI
Canaan
CAN
Intchains Group
ICG
US Stock MarketDetailed Quotes
LGVN Longeveron
- 1.510
- +0.030+2.03%
Close Feb 26 16:00 ET
22.40MMarket Cap-0.27P/E (TTM)
1.525High1.460Low63.05KVolume1.480Open1.480Pre Close94.22KTurnover0.54%Turnover RatioLossP/E (Static)14.84MShares6.40052wk High0.87P/B17.64MFloat Cap0.77152wk Low--Dividend TTM11.68MShs Float450.000Historical High--Div YieldTTM4.39%Amplitude0.770Historical Low1.494Avg Price1Lot Size
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Longeveron Stock Forum
On its way today
Pain staking searches will always produce results. Patience is a virtue
1. My strategy is to find an item that has immediate results in order to sell and recuperate the initial investment by selling 50% of the initial shares purchased. (SureBet!)
2. Leaving the remaining 50% to hit as a limit sale at the obnoxious goal minus 20% for a safer bet. (Long-TermSpecial)
The Father of Stocks: Laying the groundwork for market an...
$Longeveron (LGVN.US)$ is scheduled to release its financial results post-market on February 28 ET.
EPS is estimated to be USD-0.36, Net Loss Narrowed 85.74% YoY.
$Neumora Therapeutics (NMRA.US)$
$Longeveron (LGVN.US)$
$Ocean Biomedical (OCEA.US)$
$Zomedica (ZOM.US)$
TheFather's portfolio up a total of 3% early this morning
Take your profits. Good luck, everyone!
My two additions for my strategy
Pain staking searches will always produce results.
1. My strategy is to find an item that has immediate results in order to sell and recuperate the initial investment by selling 50% of the initial shares purchased. (SureBet!)
2. Leaving the remaining 50% to hit as a limit sale at the obnoxious goal minus 20% for a safer bet. (Long-TermSpecial)
The Father of Stocks: Laying...
The WHO's approval of 'laromestrocel' as the International Non-proprietary Name for Lomecel-B™ marks a important advancement in Longeveron's commercialization strategy. This milestone carries significant implications beyond mere nomenclature - it represents international recognition and standardization of the therapy's identity, facilitating global regulatory processes and market access preparations.
The dual-indication strategy targeting both Alzh...
Breakthrough Alzheimer's Treatment Gets Official WHO Recognition - Major Milestone for Rare Disease Therapy
Longeveron® Announces World Health Organization Approval of "laromestrocel" as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™
Tuesday, 18th February at 9:25 am
Cellular therapy Lomecel-B™ has been granted an International Non-proprietary Name (INN) of "laromestrocel" on the INN List issued by the World Health Organization (WHO)
Lomecel-B™ is a proprietary, scalable, allogeneic cellular therapy being evaluated in Alzheimer's disease and hypoplastic ...
When is Longeveron (LGVN) presenting at the Emerging Growth Virtual Conference?
Longeveron (LGVN) is presenting at the Emerging Growth Virtual Conference on February 19, 2025, from 3:10 to 3:20 p.m. ET.
How long will the LGVN conference presentation replay be available?
The webcast replay will be available on Longeveron's website for 180 days following the conference.
How can investors s...
No comment yet